previous post
Neurology Update: Rare Diseases
next post
Neurology Update: Epilepsy
You may also like

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
December 2, 2020
Take our EAN Survey on General Neurology for a chance to win free registration and accommodation for EAN 2024!
May 25, 2023